DD
Delfi Diagnostics, Inc.
SEC filingBiotechnology · Palo Alto, CA
Amount raised$34.3Msold at filing
Total offering$60M$25.7M still open
Investors in the raise50count reported to the SEC
FiledDec 18, 2025first sale Dec 1, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Peter B. BachExecutive Officer
Lee-Ann B. Smith-FreemanExecutive Officer
Victor B. VelculescuDirector
Susan TousiExecutive Officer, Director
Amoolya B. SinghExecutive Officer
Elizabeth B. HomansDirector
Rishi B. GuptaDirector
Jacob B. Van NaardenDirector
Michael B. DybbsDirector
Greg B. YapDirector
Justin B. KaoDirector
Executive officers, directors and promoters as listed on the Form D.